| Inflammation biomarkers and pathways | Lifetime | 26 | US 11 | 97.71 |
| Asthma and respiratory diseases | Lifetime | 543 | US 200 | 98.74 |
| Mesenchymal stem cell research | Lifetime | 410 | US 149 | 97.97 |
| Vitamin D Research Studies | Lifetime | 256 | US 125 | 98.07 |
| General Medical Therapies and Clinical Treatment Research | Lifetime | 43 | US 14 | 95.74 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 376 | US 162 | 97.43 |
| IL-33, ST2, and ILC Pathways | Lifetime | 267 | US 122 | 97.35 |
| Protease and Inhibitor Mechanisms | Lifetime | 759 | US 318 | 95.88 |
| Pediatric health and respiratory diseases | Lifetime | 991 | US 326 | 94.37 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 981 | US 400 | 93.27 |
| Advanced Glycation End Products research | Lifetime | 825 | US 214 | 91.86 |
| Vitamin C and Antioxidants Research | Lifetime | 770 | US 314 | 91.55 |
| Kawasaki Disease and Coronary Complications | Lifetime | 679 | US 183 | 89.00 |
| Protein Tyrosine Phosphatases | Lifetime | 692 | US 257 | 88.47 |
| Biomarkers in Disease Mechanisms | Lifetime | 561 | US 150 | 85.61 |
| Calpain Protease Function and Regulation | Lifetime | 392 | US 150 | 86.19 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 15 | US 5 | 98.44 |
| Diabetic Foot Ulcer Assessment and Management | 2021-2025 | 49 | US 15 | 97.09 |
| Inflammation biomarkers and pathways | 2021-2025 | 6 | US 3 | 94.90 |
| Wound Healing and Treatments | 2021-2025 | 209 | US 22 | 95.25 |
| Shoulder Injury and Treatment | 2021-2025 | 305 | US 164 | 96.32 |
| Mesenchymal stem cell research | 2021-2025 | 189 | US 30 | 93.30 |
| Tendon Structure and Treatment | 2021-2025 | 193 | US 53 | 93.01 |
| Advanced Glycation End Products research | 2021-2025 | 100 | US 6 | 89.26 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 93 | US 13 | 89.17 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 549 | US 134 | 86.65 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 358 | US 110 | 87.22 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 865 | US 321 | 78.81 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 917 | US 296 | 74.45 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 625 | US 147 | 69.41 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 997 | US 239 | 70.09 |
| Apelin-related biomedical research | 2021-2025 | 765 | US 115 | 31.81 |
